During the past decade, Wu Han Tongji Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wu Han Tongji Hospital" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Capital Medical University" with 2 trials sponsored, "Loxo Oncology, Inc." with 2 trials sponsored, "Shanghai Mental Health Center" with 2 trials sponsored and "China Academy of Chinese Medical Sciences" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wu Han Tongji Hospital" #1 collaborator was "Affiliated Hospital of North Sichuan Medical College" with 2 trials as a collaborator, "Anshan Central Hospital" with 2 trials as a collaborator, "Baotou Central Hospital" with 2 trials as a collaborator, "Beijing Chao Yang Hospital" with 2 trials as a collaborator and "Beijing Geriatric Hospital" with 2 trials as a collaborator. Other collaborators include 125 different institutions and companies that were collaborators in the rest 72 trials.

According to Clinical.Site data, the most researched conditions in "Wu Han Tongji Hospital" are "Major Depressive Disorder" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Familial Alzheimer Disease (FAD)" (2 trials), "Small Lymphocytic Lymphoma" (2 trials) and "Acute Stroke" (1 trials). Many other conditions were trialed in "Wu Han Tongji Hospital" in a lesser frequency.

Most popular intervention types in "Wu Han Tongji Hospital" are "Drug" (10 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Abemaciclib" (2 trials), "Anyu Peibo" (2 trials), "Pirtobrutinib" (2 trials) and "Abiraterone Acetate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wu Han Tongji Hospital" are 10 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Wu Han Tongji Hospital". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Wu Han Tongji Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wu Han Tongji Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".